ESC Premium Access

A randomised, placebo-controlled trial of the effects of IV serelaxin on myocardial blood flow and vascular function in patients with stable coronary artery disease (CAD).

Congress Presentation

About the speaker

Doctor David Corcoran

Queen Elizabeth University Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)
0 follower

16 more presentations in this session

Automated ECG quantification of myocardial scar in patients with and without conduction defects: correlation with myocardial perfusion imaging and clinical outcome in acute heart failure patients

Speaker: Doctor P. Badertscher (Basel, CH)


The recovery of pulsatile hemodynamics during hospitalization in patients with heart failure with reduced, mid-range and preserved ejection fraction

Speaker: Assistant Professor W. Huang (Taipei, TW)


The prognostic implication of the diuretic and natriuretic responses to the combined administration of loop diuretics and tolvaptan in patients with acute decompensated heart failure

Speaker: Doctor T. Sakaguchi (Osaka, JP)


Furosemide versus bumetanide; a deep dive into national heart failure audit (England & Wales)

Speaker: Doctor A. shoaib (Stoke-on-Trent, GB)


Incidence and in-hospital case fatality of acute decompensated heart failure in chile: a stratified analysis by gender

Speaker: Assistant Professor F. Diaz (Santiago, CL)


Access the full session

Poster session 3 - Acute Heart Failure (AHF)

Speakers: Doctor D. Corcoran, Doctor P. Badertscher, Assistant Professor W. Huang, Doctor T. Sakaguchi, Doctor A. shoaib...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb